Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 27, 2019 - Issue 6
Submit an article Journal homepage
268
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor

Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma

Gerard ReidDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, Northern Ireland;Department of Ophthalmology, Warrington & Holton Hospitals NHS Foundation Trust, Lovely Lane, Warrington, UKCorrespondence[email protected]
,
Paul LoriganDepartment of Medical Oncology, The Christie Clinic, Manchester, UK
,
Heinrich HeimannDepartment of Ocular Oncology, The Royal Liverpool University Hospital, Liverpool, UK
&
Marta HovanDepartment of Ophthalmology, Warrington & Holton Hospitals NHS Foundation Trust, Lovely Lane, Warrington, UK
Pages 1012-1015 | Received 08 May 2017, Accepted 27 Mar 2018, Published online: 19 Apr 2018

References

  • Naidoo J, Page DB, Li BT, et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol. September 2015;mdv383–17. doi:10.1093/annonc/mdv383.
  • Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev. 2016;44(C):51–60. doi:10.1016/j.ctrv.2016.02.001.
  • Abu Samra K, Valdes-Navarro M, Lee S, Swan R, Foster CS, Anesi SD. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab. Ejo. 2016;26(3):e46–e48. doi:10.5301/ejo.5000724.
  • Taylor SC, Hrisomalos F, Linette GP, Rao PK. A case of recurrent bilateral uveitis independently associated with dabrafenib and pembrolizumab therapy. Am J Ophthalmol Case Rep. 2016;2(C):23–25. doi:10.1016/j.ajoc.2016.04.004.
  • Hanna KS. A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma. Pharmacotherapy. September 2016;1–14. doi:10.1002/phar.1839.
  • Basilious A, Lloyd JC. Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: case report. Can J Ophthalmol. 2016;51(1):e4–e6. doi:10.1016/j.jcjo.2015.09.008.
  • Stead RE, Juma Z, Turner S, Jones LD, Sung VCT. A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis. Br J Ophthalmol. 2016;100(6):727–730. doi:10.1136/bjophthalmol-2015-307799.
  • Crosson JN, Laird PW, Debiec M, Bergstrom CS, Lawson DH, Yeh S. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with Ipilimumab for metastatic melanoma. J Immunotherapy. 2015;38(2):80–84. doi:10.1097/CJI.0000000000000066.
  • Arai T, Harada K, Usui Y, Irisawa R, Tsuboi R. Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient. J Dermatol. September 2016;1–2. doi:10.1111/1346-8138.13612.
  • Morse LS, McCuen BW. The use of silicone oil in uveitis and hypotony. Retina. 1991;11(4):399–404. doi:10.1097/IAE.0b013e3181b32f06.
  • De Smet MD, Gunning F, Feenstra R. The surgical management of chronic hypotony due to uveitis. Eye. 2004;19(1):60–64. doi:10.1038/sj.eye.6701425.
  • Kapur R, Birnbaum AD, Goldstein DA, et al. Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina (Philadelphia, Pa). 2010;30(1):140–145. doi:10.1097/IAE.0b013e3181b32f06.
  • Kucukerdonmez C, Beutel J, Bartz-Schmidt KU, Gelisken F. Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol. 2009;93(2):235–239. doi:10.1136/bjo.2008.143834.
  • Tosi GM, Schiff W, Barile G, Yoshida N, Chang S. Management of severe hypotony with intravitreal injection of viscoelastic. Am J Ophthalmol. 2005;140(5):952–954. doi:10.1016/j.ajo.2005.06.019.
  • Ohira A, Chihara E, Soji T. Egress route of emulsified 20 centistokes silicone oil from anterior chamber of rabbit. Curr Eye Res. 1994;13(7):489–495.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.